D 75N95022Q00438-CSS.pdf

COMBINED SYNOPSIS / SOLICITATION

75N95022Q00438

TITLE: Testing of compounds in CYP inhibition, hERG inhibition, PPB, and Caco-2 permeability assays

(i) This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in Subpart 12.6 as supplemented with additional information included in this notice.

This announcement constitutes the only solicitation; quotations are being requested and a written solicitation will not be issued.

(ii) The solicitation number is 75N95022Q00438 and the solicitation is issued as a request for quotation (RFQ). This acquisition is for a commercial item and is conducted under the authority of the Federal Acquisition Regulation (FAR) Part 13 - Simplified Acquisition Procedures and FAR Part 12 - Acquisition of Commercial Items, and is not expected to exceed the simplified acquisition threshold.

(iii) The solicitation document and incorporated provisions and clauses are those in effect through

Federal Acquisition Circular (FAC) 2022-07 effective August 10, 2022.

(iv) The associated NAICS code is 541380 and the Small Business size standard is $16.5M. This requirement is being competed with full and open competition and no set-aside restrictions are applicable.

DESCRIPTION

(v) The National Center for Advancing Translational Sciences (NCATS), within the National

Institutes of Health (NIH), requires the testing of compounds in CYP inhibition, hERG inhibition, PPB, and Caco-2 permeability assays.

See attached Statement of Work for complete requirement details.

(vi) The anticipated period of performance is six (6) weeks after receipt of compounds.

Respondents may propose an alternative period of performance.

EVALUATION AND AWARD

(vii) The anticipated award date is September 7, 2022.

(viii) The Government plans to make one firm, fixed price award resulting from this solicitation. The resulting award will be made to the vendor who submitted the quote that is the most advantageous to the Government, price and other factors considered. The Government will use a trade-off approach and comparative evaluations to determine which quotation is the best value, in consideration of the following evaluation criteria:

1. Technical Capability: The ability to perform all four (4) tasks, and the proposed period of performance.

2. Past Performance: Past performance performing similar services. The Government may use any source of available past performance information (see FAR 13.106-2(b)(3)).

3. Price: The total price.

SUBMISSION INSTRUCTIONS

(ix) All responses to this RFQ must be received by 9:00am Eastern Time on Wednesday, August 31, 2022 and must reference the solicitation number cited above. Responses must be submitted via email to Kimberly Espinosa at kimberly.espinosa@nih.gov.

(x) This is an RFQ. This request does not commit the Government to pay any costs incurred in the preparation of the submission of this quotation or to contract for supplies or service.

Supplies are of domestic origin unless otherwise indicated by quoter. Any representations and/or certifications attached to this RFQ must be completed by the quoter.

(xi) Responses to this RFQ must include sufficient information to establish the interested parties’ bona-fide capabilities of providing the product or service. Responses may exceed capability or performance characteristics of the solicitation's requirements. The Government reserves the right, but is not required, to award to a response that exceeds capability or performance characteristics of the solicitation's requirements if it provides a benefit to the Government.

(xii) Responses must also include the Unique Entity Identifier (UEI) (which recently replaced the

DUNS number), the Taxpayer Identification Number (TIN), the certification of business size, the completed representation in FAR Provision 52.229-11 (attached), and a quotation that includes:

1. The total price,

2. Individual prices for each task,

3. The period of performance. Respondents should confirm their ability to perform the tasks within six (6) weeks after receipt of compounds, or propose an alternative period of performance.

4. Prompt payment discount terms,

5. Product or catalog number(s),

6. Service description, and

7. Any other information or factors that may be considered in the award decision. Such factors may include: special features required for effective program performance; trade-in considerations; warranty considerations; maintenance availability; and environmental and energy efficiency considerations.

mailto:kimberly.espinosa@nih.gov

(xiii) For information about this RFQ, contact Kimberly Espinosa, Contracting Officer, at 301-827- 3546 or kimberly.espinosa@nih.gov.

(xiv) All responsible sources may submit a bid, proposal, or quotation which shall be considered by the agency.

TERMS AND CONDITIONS, PROVISIONS, AND REPRESENTATIONS

(xv) The provision at FAR 52.252-1, Solicitation Provisions Incorporated by Reference (Feb

1998). This solicitation incorporates one or more solicitation provisions by reference, with the same force and effect as if they were given in full text. Upon request, the Contracting Officer will make their full text available. The offeror is cautioned that the listed provisions may include blocks that must be completed by the offeror and submitted with its quotation or offer. In lieu of submitting the full text of those provisions, the offeror may identify the provision by paragraph identifier and provide the appropriate information with its quotation or offer. Also, the full text of a solicitation provision may be accessed electronically at www.acquisition.gov.

The following provisions apply to this acquisition and are incorporated by reference:

1. FAR Provision 52.204-7, System for Award Management (Oct 2018)

2. FAR Provision 52.204-16, Commercial and Government Entity Code Reporting (Aug 2020)

3. FAR Provision 52.212-3, Offeror Representations and Certifications—Commercial Products and Commercial Services (Nov 2021)

(xvi) The clause at FAR 52.252-2, Clauses Incorporated by Reference (Feb 1998). This contract incorporates one or more clauses by reference, with the same force and effect as if they were given in full text. Upon request, the Contracting Officer will make their full text available. Also, the full text of a clause may be accessed electronically at www.acquisition.gov.

In addition to the clauses checked in FAR 52.212-5 (attached), the following clauses also apply to this acquisition and are incorporated by reference:

1. FAR Clause 52.204-13, System for Award Management Maintenance (Oct 2018)

2. FAR Clause 52.204-18, Commercial and Government Entity Code Maintenance (Aug 2020)

3. FAR Clause 52.212-4, Contract Terms and Conditions – Commercial Products and

Commercial Services (Nov 2021)

4. HHSAR Clause 352.222-70, Contractor Cooperation in Equal Employment Opportunity

Investigations (December 18, 2015)

5. The clause at FAR 52.227-14, Rights in Data-General (May 2014). Under 52.227-14(c)(1), the contractor must obtain approval from the contracting officer to assert copyright in any data first produced in performance of this contract and published in academic, technical or professional journals, symposia proceedings, or similar works. Under 52.227-14(d)(2), the contractor must obtain approval from the contracting officer to use, release to others, reproduce, distribute, or publish any data first produced or specifically used by the contractor in the performance of this contract.

6. The clause at HHSAR 352.224-71 Confidential Information (December 18, 2015) (c)(2)(i) The publication or dissemination of the following types of information are restricted under this contract: 1) results of the analysis.

(c)(2)(ii) The reason for restricting the types of information identified in subparagraph (i) is:

1) The analysis results are commercial confidential information and may be used in the development of a future commercial treatment.

(xvii) The Defense Priorities and Allocations System (DPAS) are not applicable to this requirement.

ATTACHMENTS

(xviii) The following are incorporated and attached in full text:

1. Statement of Work

2. The provision at FAR 52.212-1, Instructions to Offerors – Commercial Products and

Commercial Services (Nov 2021) (Tailored)

3. FAR Provision 52.204-26, Covered Telecommunications Equipment or Services-

Representation (Oct 2020)

4. The clause at FAR 52.212-5, Contract Terms and Conditions Required to Implement

Statutes or Executive Orders–Commercial Products and Commercial Services (May 2022)

5. NIH Electronic Invoice Submission Instructions without IPP (April 21, 2022)